Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and Northern blot analysis

1994 ◽  
Vol 18 (7) ◽  
pp. 475-484 ◽  
Author(s):  
Gerburg Wulf ◽  
Hildegard Kluding ◽  
Anthony D.Ho ◽  
Maria Doerner ◽  
Hartmut Doehner ◽  
...  
2008 ◽  
Vol 149 (4) ◽  
pp. 161-167 ◽  
Author(s):  
Tamás Szendrei ◽  
Tamás Magyarlaki ◽  
Gábor Kovács ◽  
Ágnes Nagy ◽  
Árpád Szomor ◽  
...  

Az utóbbi években krónikus lymphoid leukaemiában új prognosztikai faktorok vizsgálata került a figyelem középpontjába. A citogenetikai eltérések, az immunglobulin-nehézlánc génmutációs státusza, a CD38- és ZAP70-expresszió mind a közelmúltban megismert prognosztikus faktorok, de kevés az adat a multidrog-rezisztencia jelentőségéről. Célok: A tanulmány célja genetikai, expressziós és funkcionális szinten jellemezni 82 krónikus lymphoid leukaemiában szenvedő beteg multidrog-rezisztenciájának sajátosságait, és vizsgálni azok összefüggését a betegek túlélésével és a kezelésre adott válasszal. Módszerek: a szerzők 66 betegnél vizsgálták az MDR-1 gén ben – Light Cycler Real Time PCR segítségével meghatározott – „Single Nucleotid Polymorphism” sajátosságot, amely irodalmi adatok szerint a P-glikoprotein expresszióját befolyásolja. Összesen 82 betegnél áramlási citometria során anti-P-glikoprotein monoklonális antitest segítségével a P-glikoprotein- expresszió t, az ún. calcein-verapamil teszttel pedig a multidrog-rezisztencia funkcióját vizsgálták. A kezelésre adott választ 35 betegnél vizsgálták, a statisztikai elemzésnél Fischer-tesztet alkalmazva. A túlélési analízist a teljes beteganyagon elvégezték ( n = 82, Log-rank-teszt). Eredmények: Az irodalmi adatokkal ellentétben a szerzők nem találtak korrelációt a vizsgált három multidrogrezisztencia-teszt között. A kezelésre adott választ vizsgálva 35 kezelt betegből 13 nonrespondernek, 22 pedig respondernek bizonyult. A P-glikoprotein-pozitív fenotípusú esetek ( n = 9) 89%-ban klinikailag nonrespondernek bizonyultak (9 P-glikoprotein-pozitív krónikus lymphoid leukaemiás beteg közül 8 nonresponder volt), a P-glikoprotein-negatív esetek ( n = 26) pedig 80%-ban jó terápiás választ mutattak (26 P-glikoprotein-negatív beteg közül 21 responder) ( p < 0,001). Az átlagos várható túlélésben is jelentős, bár nem szignifikáns ( p = 0,106) különbséget észleltek (84 vs 203 hónap). Következtetések: A vizsgált három laboratóriumi paraméter közül a P-glikoprotein sejtfelszíni jelenléte a leginkább releváns adat krónikus lymphoid leukaemiában a kemorezisztencia előjelzésére és a túléléssel kapcsolatban is prognosztikai faktorként értékelhető.


2012 ◽  
Vol 2012 ◽  
pp. 1-4 ◽  
Author(s):  
Roni M. Shtein ◽  
Susan G. Elner ◽  
Zong-Mei Bian ◽  
Victor M. Elner

Purpose. To determine time course of effect of lipopolysaccharide (LPS) on production of interleukin-8 (IL-8) and monocyte chemotactic protein (MCP) by cultured human corneal stromal cells.Methods. Human corneal stromal cells were harvested from donor corneal specimens, and fourth to sixth passaged cells were used. Cell cultures were stimulated with LPS for 2, 4, 8, and 24 hours. Northern blot analysis of IL-8 and MCP gene expression and ELISA for IL-8 and MCP secretion were performed. ELISA results were analyzed for statistical significance using two-tailed Student'st-test.Results. Northern blot analysis demonstrated significantly increased IL-8 and MCP gene expression after 4 and 8 hours of exposure to LPS. ELISA for secreted IL-8 and MCP demonstrated statistically significant increases (P<0.05) after corneal stromal cell stimulation with LPS.Conclusions. This paper suggests that human corneal stromal cells may participate in corneal inflammation by secreting potent leukocyte chemotactic and activating proteins in a time-dependent manner when exposed to LPS.


1988 ◽  
Vol 16 (5) ◽  
pp. 2354-2354 ◽  
Author(s):  
Nathalie Denis ◽  
Daniel Corcos ◽  
Jacques Kruh ◽  
Alain Kitzis

FEBS Letters ◽  
1995 ◽  
Vol 372 (2-3) ◽  
pp. 151-156 ◽  
Author(s):  
Masato Katsuyama ◽  
Nobuhiro Nishigaki ◽  
Yukihiko Sugimoto ◽  
Kimiko Morimoto ◽  
Manabu Negishi ◽  
...  

1986 ◽  
Vol 159 (1) ◽  
pp. 227-232 ◽  
Author(s):  
Edouard W. Khandjian ◽  
Claude Méric

Development ◽  
1991 ◽  
Vol 111 (4) ◽  
pp. 933-944 ◽  
Author(s):  
A. Nishiyama ◽  
K.J. Dahlin ◽  
W.B. Stallcup

NG2 is a chondroitin sulfate proteoglycan previously found to be expressed by glial progenitor cells of the O2A lineage. We have examined the expression of NG2 in the developing rat limb by immunohistochemistry and northern blot analysis. Staining of embryonic day 14 (E14) rat limb bud sections with polyclonal and monoclonal anti-NG2 antibodies reveals reactivity in the precartilaginous mesenchymal condensation. The staining intensity increases with the differentiation of chondrocytes until E16. NG2 staining is not detected in the mature hypertrophic chondrocytes of E17 and postnatal day 3 (P3) limbs even after treatment of the sections with hyaluronidase or collagenase. Immuno-precipitations with anti-NG2 antibody using 125I-labeled limb cells in culture showed a 400 to 800 × 10(3) Mr proteoglycan species with a core protein size of 300 × 10(3) Mr, comparable to NG2 from O2A cells and neural cell lines. Northern blot analysis reveals the expression of an 8.9 kb mRNA in E16 limbs and at a lower level in P1 cartilage. The northern blot analyses also show that NG2 is distinct from the large aggregating proteoglycan of the cartilage. Our results indicate that in the developing limb cartilage, as in the differentiating oligodendrocytes, NG2 is present on immature cells in the process of differentiating, but its expression is downregulated as terminal differentiation of chondrocytes takes place.


1997 ◽  
Vol 272 (4) ◽  
pp. H1636-H1642
Author(s):  
V. O. Rybin ◽  
P. M. Buttrick ◽  
S. F. Steinberg

We recently identified a developmental decline in protein kinase C (PKC) isoform expression, at the level of the protein, in rat ventricular myocardium. To investigate mechanisms regulating PKC isoform expression in cardiac tissue, this study uses Northern blot analysis to compare the abundance of PKC isoform mRNAs in neonatal and adult rat ventricular myocardium. PKC-epsilon protein and mRNA were detected in both neonatal and adult rat ventricular myocardial preparations. In contrast, coordinate postnatal declines in the abundance of PKC-alpha and PKC-delta proteins and transcripts were identified. An antiserum raised against the COOH-terminal sequence of PKC-zeta detected abundant immunoreactivity in neonatal, but not adult, ventricular myocytes. However, PKC-zeta transcripts were not detectable in the heart either by Northern blot analysis or a reverse transcriptase-polymerase chain reaction approach, indicating that neither the myocytes nor the contaminating cellular elements in the heart express PKC-zeta. Rather, PKC-lambda, another atypical PKC isoform that is structurally highly homologous to PKC-zeta, was detected at the protein and mRNA level in neonatal, but not adult, ventricular myocardium. Taken together, these results establish that developmental declines in calcium-sensitive, novel, and atypical PKC isoforms are paralleled by changes in the levels of the mRNAs encoding these proteins, suggesting transcriptional regulation of PKC during normal cardiac development. The results of this study further identify PKC-lambda as the atypical PKC isoform expressed by the immature ventricle.


Sign in / Sign up

Export Citation Format

Share Document